-
-
-
-
-
-
News
-
-
Contact UsThe company focuses on the research, development, production, and sales of chemical raw materials and their formulations. All products have passed national GMP certification, and core products have successively passed official pharmaceutical regulatory certifications from multiple countries, including the EU EDQM, US FDA, Japanese PMDA, and South Korean MFDS. Following its successful listing on the Shenzhen Stock Exchange's ChiNext board on April 4, 2023, Keyuan Pharmaceutical has entered a phase of rapid development driven by both digital intelligence and capital, with its business spanning dozens of countries and regions worldwide.
Serial Number
Product Name
Quality Standard
Role and Usage
2023 Shandong Province's Second Batch of Technological Innovation Projects -- (Paotaisong, nifedipine)
2023 Shandong Province's first batch of technological innovation projects -- (Furosemide)
2022 Shandong Province's Second Batch of Technological Innovation Projects -- (Qu Pi Bu Tong)
2022 Shandong Province's first batch of technological innovation projects -- (Esmolol hydrochloride)
2021 Shandong Province's Second Batch of Technological Innovation Projects -- (Ruxolitinib Hydrochloride, Propafenone Hydrochloride)
2021 Shandong Province's first batch of technological innovation projects -- (potassium diclofenac)
2020 Shandong Province's first batch of technological innovation projects -- (Clarithromycin lactose acid)
2019 Shandong Province Fourth Batch of Technological Innovation Projects -- (Voglibose)
2018 Shandong Province Third Batch of Technological Innovation Projects -- (Parecoxib sodium, Prulofloxacin)
2017 Shandong Province's first batch of technological innovation projects -- (Optimization of the synthesis process of raw material mecobalamin)
2016 Shandong Province Fourth Batch of Technological Innovation Projects -- (Research on Green Technology for Gliclazide)
Address: No. 26, Keyuan Street, Shanghe County, Jinan City, Shandong Province
Free Service Hotline